Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 4 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Immunotherapy approaches for malignant pleural mesothelioma.
Nat Rev Clin Oncol. 2022 Sep;19(9):573-584. doi: 10.1038/s41571-022-00649-7. Epub 2022 Jul 1.
Nat Rev Clin Oncol. 2022.
PMID: 35778611
Review.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Fennell DA, Ewings S, Ottensmeier C, Califano R, Hanna GG, Hill K, Danson S, Steele N, Nye M, Johnson L, Lord J, Middleton C, Szlosarek P, Chan S, Gaba A, Darlison L, Wells-Jordan P, Richards C, Poile C, Lester JF, Griffiths G; CONFIRM trial investigators.
Fennell DA, et al.
Lancet Oncol. 2021 Nov;22(11):1530-1540. doi: 10.1016/S1470-2045(21)00471-X. Epub 2021 Oct 14.
Lancet Oncol. 2021.
PMID: 34656227
Free PMC article.
Clinical Trial.
Item in Clipboard
Progress in the Management of Malignant Pleural Mesothelioma in 2017.
McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M, Yang H, Peikert T.
McCambridge AJ, et al.
J Thorac Oncol. 2018 May;13(5):606-623. doi: 10.1016/j.jtho.2018.02.021. Epub 2018 Mar 8.
J Thorac Oncol. 2018.
PMID: 29524617
Free PMC article.
Review.
Item in Clipboard
Novel insights into mesothelioma biology and implications for therapy.
Yap TA, Aerts JG, Popat S, Fennell DA.
Yap TA, et al.
Nat Rev Cancer. 2017 Jul 25;17(8):475-488. doi: 10.1038/nrc.2017.42.
Nat Rev Cancer. 2017.
PMID: 28740119
Review.
Item in Clipboard
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial.
Fennell DA, Kirkpatrick E, Cozens K, Nye M, Lester J, Hanna G, Steele N, Szlosarek P, Danson S, Lord J, Ottensmeier C, Barnes D, Hill S, Kalevras M, Maishman T, Griffiths G.
Fennell DA, et al.
Trials. 2018 Apr 18;19(1):233. doi: 10.1186/s13063-018-2602-y.
Trials. 2018.
PMID: 29669604
Free PMC article.
Item in Clipboard
BTS guideline for the investigation and management of malignant pleural mesothelioma.
Woolhouse I, Bishop L, Darlison L, de Fonseka D, Edey A, Edwards J, Faivre-Finn C, Fennell DA, Holmes S, Kerr KM, Nakas A, Peel T, Rahman NM, Slade M, Steele J, Tsim S, Maskell NA.
Woolhouse I, et al.
BMJ Open Respir Res. 2018 Feb 14;5(1):e000266. doi: 10.1136/bmjresp-2017-000266. eCollection 2018.
BMJ Open Respir Res. 2018.
PMID: 29531746
Free PMC article.
Item in Clipboard
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.
Woolhouse I, Bishop L, Darlison L, De Fonseka D, Edey A, Edwards J, Faivre-Finn C, Fennell DA, Holmes S, Kerr KM, Nakas A, Peel T, Rahman NM, Slade M, Steele J, Tsim S, Maskell NA.
Woolhouse I, et al.
Thorax. 2018 Mar;73(Suppl 1):i1-i30. doi: 10.1136/thoraxjnl-2017-211321.
Thorax. 2018.
PMID: 29444986
No abstract available.
Item in Clipboard
Cite
Cite